Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia
Clinical trial NCT01556594 · COMPLETED
Trial details
- NCT number
- NCT01556594
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2012-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.